U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047677) titled 'Ex Vivo Evaluation on Human Tissue of the Binding of Experimental Radiolabeled Ligands' on June 23.
Brief Summary: The HERO project aims to structure an ex vivo screening platform, based on anonymized human tissues, to early assess the tissue fixation of experimental ligands in an ethical, translational approach that complies with the principles of the 3Rs (Replacement, Reduction, Refinement).
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Early Assessment of Tissue Uptake of Experimental Ligands
Intervention:
OTHER: Early assessment of tissue uptake of experimental ligands
Ex vivo evaluation of the binding of...